Browse by author
Lookup NU author(s): Dr Clive Kelly
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
© 2021, Royal Academy of Medicine in Ireland.Introduction: There is considerable overlap between the clinical manifestations of covid-19 pneumonia and the acute interstitial lung disease seen in certain rheumatic disorders. In addition, pulmonary fibrosis is increasingly recognised as a potentially serious consequence of both. Methods: This review explores this overlap of clinical features, risk factors and causation, offering insights into the immune mechanisms that contribute to both sets of disorders. Results: The therapeutic role of immunosuppression and biologic agents in the treatment of covid-19 is explained in the light of this. Discussion: We propose how lessons learned from the insights recently gained into each disorder can improve our insight into immunological mechanisms and application of therapeutic interventions in the other.
Author(s): Williamson J, Black L, Black A, Koduri G, Kelly C
Publication type: Review
Publication status: Published
Journal: Irish Journal of Medical Science
Year: 2022
Volume: 191
Pages: 1-5
Print publication date: 01/02/2022
Online publication date: 10/02/2021
Acceptance date: 02/02/2021
ISSN (print): 0021-1265
ISSN (electronic): 1863-4362
Publisher: Springer Science and Business Media Deutschland GmbH
URL: https://doi.org/10.1007/s11845-021-02545-y
DOI: 10.1007/s11845-021-02545-y
